No evidence for a putative involvement of platelet-activating factor in systemic lupus erythematosus without active nephritis

Background: Platelet-activating factor (PAF) seems to be implicated in systemic lupus erythematosus (SLE) patients with associated renal diseases.Aims: In this study, we ensured the role of PAF in SLE patients without renal complications.

Bibliographic Details
Main Authors: Yves Denizot, Eric Liozon, Laurence Guglielmi, Kim Ly, Pascale Soria, Véronique Loustaud, Elisabeth Vidal, Marie Odile Jauberteau
Format: Article
Language:English
Published: Hindawi Limited 2003-01-01
Series:Mediators of Inflammation
Subjects:
Online Access:http://dx.doi.org/10.1080/0962935031000097718
Description
Summary:Background: Platelet-activating factor (PAF) seems to be implicated in systemic lupus erythematosus (SLE) patients with associated renal diseases.Aims: In this study, we ensured the role of PAF in SLE patients without renal complications.
ISSN:0962-9351
1466-1861